an overview of the ongoing sierra trial in relapsed/refractory aml
Published 5 years ago • 245 plays • Length 2:12Download video MP4
Download video MP3
Similar videos
-
0:52
evaluating older patients with acute myeloid leukemia in sierra trial
-
0:56
ongoing studies for patients with relapsed/refractory aml
-
1:35
sierra trial delivers initial data for older patients with aml
-
2:07
a phase iii trial evaluating iomab-b prior to hct in relapsed/refractory aml
-
0:59
the role of radioimmunoconjugates in aml treatment: insights from the sierra trial
-
4:46
sierra trial updates: apamistamab in aml
-
1:33
antibody-based therapy to treat aml: radioimmunoconjugates
-
2:26
overview of 4 fda approvals in acute myeloid leukemia
-
4:02
enasidenib in midh relapsed and refractory aml
-
4:42
gene-based treatments show positive outcomes in aml
-
7:26
targeting flt3 in patients with relapsed/refractory aml
-
2:15
an overview of the calgb 10603 trial in aml
-
1:06
gilteritinib monotherapy shows potential for treatment of relapsed/refractory flt3 aml
-
2:54
how novel agents & individualized treatment approaches are improving outcomes in patients with aml
-
2:18
advances changing the treatment landscape of aml
-
4:55
the challenges in aml-mrc
-
0:39
aml clinical trials: early stage vs. relapse/refractory patients
-
1:20
dr. ravandi on relapse/refractory aml
-
5:08
finding novel treatment options for relapsed/progressing aml